A thread for discussing Retatrutide in the context of exercise — endurance, resistance training, recovery, and muscle retention. This is an active area of research interest across the whole GLP-1/GIP/glucagon drug class, not just Retatrutide specifically, so general incretin-class research is fair game here too.
Topics for this thread
- Endurance: how appetite and energy-intake changes during treatment may affect endurance training capacity
- Resistance training: how members are approaching strength training alongside significant weight loss
- Recovery: observations on recovery time and energy levels
- Muscle retention: a widely discussed open question across the entire incretin drug class — rapid weight loss can include loss of lean mass alongside fat mass, and researchers are actively studying how to mitigate that (resistance training and adequate protein intake are commonly discussed strategies in the broader literature)
- General fitness observations
Retatrutide-specific body-composition data (lean vs. fat mass breakdowns) is limited in what’s been publicly reported so far — most of what’s published focuses on total weight loss and A1C. If you come across peer-reviewed body-composition data specific to Retatrutide, the Research News thread is a great place to share it, and linking it here too would be useful.
Share what you’re noticing, but please don’t frame anecdotal fitness experiences as proven outcomes — and skip specific training-plus-medication protocol recommendations, which fall outside what this forum supports.
